Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Acorda Therapeutics, Inc.
(NQ:
ACOR
)
32.40
USD
UNCHANGED
Official Closing Price
/ Updated:
8:10 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Acorda Therapeutics, Inc.
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Acorda Therapeutics to Present at the JPMorgan 26th Annual Healthcare Conference
December 31, 2007
from
Business Wire News Releases
Acorda Therapeutics Completes Enrollment of Phase 3 Clinical Trial of Fampridine-SR
November 30, 2007
from
Business Wire News Releases
Acorda Therapeutics to Present at the BMO Capital Markets Focus on Healthcare Conference
November 27, 2007
from
Business Wire News Releases
Acorda Therapeutics to Present at Two Upcoming Conferences
November 20, 2007
from
Business Wire News Releases
Acorda Therapeutics CEO Inducted into Spinal Cord Injury Hall of Fame
November 09, 2007
from
Business Wire News Releases
Acorda Therapeutics Reports Third Quarter 2007 Financial Results
November 06, 2007
from
Business Wire News Releases
Acorda Therapeutics to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
October 31, 2007
from
Business Wire News Releases
Acorda Therapeutics to Host Conference Call and Webcast to Report Third Quarter 2007 Financial Results on November 6, 2007
October 30, 2007
from
Business Wire News Releases
Scientists Show Monoclonal Antibody Leads to Repair of Myelin Sheath in Laboratory Study of Multiple Sclerosis
October 16, 2007
from
Business Wire News Releases
Acorda Therapeutics Files Lawsuit Against Apotex Corp. and Apotex Inc. Relating to Zanaflex Capsules(TM)
October 11, 2007
from
Business Wire News Releases
Acorda Therapeutics Selected to be Inaugural Member of the NASDAQ NeuroInsights Neurotech Index
September 25, 2007
from
Business Wire News Releases
Acorda Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
September 19, 2007
from
Business Wire News Releases
Acorda Therapeutics Announces Receipt of ANDA Filing for Zanaflex Capsules(TM)
September 05, 2007
from
Business Wire News Releases
Acorda Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference
September 04, 2007
from
Business Wire News Releases
Acorda Therapeutics Reports Second Quarter 2007 Financial Results
August 07, 2007
from
Business Wire News Releases
Acorda Therapeutics to Host Conference Call and Webcast to Report Second Quarter 2007 Financial Results on August 7, 2007
July 31, 2007
from
Business Wire News Releases
Acorda Therapeutics Announces Resignation of Mary Fisher
July 20, 2007
from
Business Wire News Releases
Acorda Therapeutics Announces Exercise of Option by Underwriters
July 06, 2007
from
Business Wire News Releases
Acorda Therapeutics Joins Russell 3000 Index
July 02, 2007
from
Business Wire News Releases
Acorda Therapeutics' President and CEO Ron Cohen, M.D. Named Ernst & Young Entrepreneur Of The Year(R) 2007 Award Winner in the Metro New York Area
June 29, 2007
Award Recognizes Entrepreneurial Excellence in Innovation
Read More
from
Business Wire News Releases
Acorda Therapeutics to Present at the Piper Jaffray Second Annual London Health Care Conference
June 14, 2007
from
Business Wire News Releases
Acorda Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock
June 08, 2007
from
Business Wire News Releases
Acorda Therapeutics to Present at the Sixth Annual Needham & Company, LLC Biotechnology & Medical Technology Conference
June 07, 2007
from
Business Wire News Releases
Acorda Therapeutics Begins Second Phase 3 Clinical Trial of Fampridine-SR in Multiple Sclerosis
June 06, 2007
from
Business Wire News Releases
Acorda Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
June 04, 2007
from
Business Wire News Releases
Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting
June 04, 2007
Data Validates Clinical Meaningfulness of Timed Walk Response
Read More
from
Business Wire News Releases
Acorda Therapeutics to Present at Friedman, Billings, Ramsey & Co., Inc. 2007 Growth Conference
May 24, 2007
from
Business Wire News Releases
Acorda Therapeutics to Present at Bank of America Health Care Conference
May 23, 2007
from
Business Wire News Releases
Acorda Therapeutics and FDA Reach Agreement on Special Protocol Assessment for Second Phase 3 Study of Fampridine-SR in Multiple Sclerosis
May 22, 2007
from
Business Wire News Releases
Acorda Therapeutics Reports First Quarter 2007 Financial Results
May 10, 2007
from
Business Wire News Releases
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here